What’s Next in the Evolution of Standards for Biologics Development
Fouad Atouf, PhD, CSO of United States Pharmacopeia (USP) feels the growing complexity of the field reinforces the need for standards ensuring product quality, consistency, and patient safety. Don't miss his insightful Thought Leader piece from our May issue. The post What’s Next in the Evolution of Standards for Biologics Development appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.